Aaron Bloomer - 23 Dec 2025 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
EVP, Chief Financial Officer
Signature
/s/ Aaron Bloomer by Mark Busch, attorney-in- fact
Issuer symbol
EXAS
Transactions as of
23 Dec 2025
Net transactions value
-$2,846,276
Form type
4
Filing time
30 Dec 2025, 16:30:03 UTC
Previous filing
17 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Bloomer Aaron EVP, Chief Financial Officer C/O EXACT SCIENCES CORP, 5505 ENDEAVOR LANE, MADISON /s/ Aaron Bloomer by Mark Busch, attorney-in- fact 30 Dec 2025 0002019003

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +38,715 +284% $0.000000 52,338 23 Dec 2025 Direct F1
transaction EXAS Common Stock Tax liability $1,746,315 -17,151 -33% $101.82 35,187 23 Dec 2025 Direct F2
transaction EXAS Common Stock Options Exercise $0 +24,384 +69% $0.000000 59,571 23 Dec 2025 Direct F1
transaction EXAS Common Stock Tax liability $1,099,961 -10,803 -18% $101.82 48,768 23 Dec 2025 Direct F2, F3
holding EXAS Common Stock 212 23 Dec 2025 Held in 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Options Exercise $0 -38,715 -100% $0.000000 0 23 Dec 2025 Common Stock 38,715 Direct F4, F5
transaction EXAS Restricted Stock Units Options Exercise $0 -24,384 -85% $0.000000 4,395 23 Dec 2025 Common Stock 24,384 Direct F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares of Common Stock retained by Exact Sciences Corporation (the "Issuer") for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 48,980 shares, Mr. Bloomer also holds, in the aggregate, an additional 4,395 unvested restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock
F4 Each restricted stock unit represents a contingent right to receive one share of common stock.
F5 This award was scheduled to vest in three equal installments on April 15, 2026, April 15, 2027, and April 15, 2028, subject to the Reporting Person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated in connection with the Section 280G Mitigation.
F6 This award was scheduled to vest in four equal installments on February 27, 2026, February 26, 2027, February 29, 2028, and February 28, 2029, subject to the Reporting Person's continued service through such vesting date but the vesting of the portion reflected herein was accelerated in connection with the Section 280G Mitigation.